RET and non-small cell lung carcinoma: However, similarly to other large studies, we have identified a significant number of subjects with RET-rearranged NSCLCs that do not meet the above criteria; therefore, all NSCLC cases should undergo comprehensive molecular testing irrespective of the clinical presentation of the disease [13,27,30].